What’s happening: A bipartisan group of U.S. representatives is leading a letter to U.S. Health and Human Services (HHS) Secretary Xavier Becerra about efforts by Johnson & Johnson (J&J) to undermine the 340B Drug Discount Program. What else to know: Hospital leaders should call or email their U.S. representative and urge them to sign on to the letter by Sept....
This content is restricted to members.
